Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series

Abstract Background Faricimab is a novel anti-vascular endothelial growth factor agent, used to treat patients with neovascular age-related macular degeneration (nAMD). This study assessed efficacy and safety of faricimab in previously treated eyes. Methods This retrospective study included previous...

Full description

Bibliographic Details

Published in:	BMC Ophthalmology
Main Authors:	Maria A. Bantounou, Mohammed Elsheikh, Adelehin Ijasan, Cynthia Santiago
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Subjects:	Anti-vascular endothelial growth factor Faricimab Vabysmo Intravitreal injection Neovascular age-related macular degeneration Switch therapy
Online Access:	https://doi.org/10.1186/s12886-025-03953-9